Aerovate Therapeutics (AVTE) Institutional Ownership → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free AVTE Stock Alerts $17.45 -0.21 (-1.19%) (As of 05/31/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Aerovate Therapeutics (NASDAQ:AVTE)Number ofInstitutional Buyers(last 12 months)13TotalInstitutional Inflows(last 12 months)$66.42MNumber ofInstitutional Sellers(last 12 months)8TotalInstitutional Outflows(last 12 months)$6.71M Get AVTE Insider Trade Alerts Want to know when executives and insiders are buying or selling Aerovate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AVTE Institutional Buying and Selling by Quarter Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Aerovate Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 Ikarian Capital LLC367,965$10.88M1.2%N/A1.277% 5/16/2024 California State Teachers Retirement System1,124$33K0.0%-38.9%0.004% 5/14/2024 EntryPoint Capital LLC3,126$92K0.1%-49.0%0.011% 5/10/2024 Vanguard Group Inc.672,275$19.88M0.0%+7.2%2.410% 2/20/2024 Eventide Asset Management LLC12,178$276K0.0%N/A0.044% 2/15/2024 Octagon Capital Advisors LP403,685$9.14M1.5%-18.8%1.459% Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024 Parkwood LLC15,786$357K0.0%-23.6%0.057% 2/15/2024 Great Point Partners LLC1,037,690$23.48M4.0%-4.9%3.750% 2/14/2024 Vestal Point Capital LP400,000$9.05M1.0%N/A1.446% 11/15/2023 Alps Advisors Inc.20,395$277K0.0%+11.3%0.074% 11/14/2023 Fred Alger Management LLC24,747$336K0.0%-57.2%0.090% 11/13/2023 Silverarc Capital Management LLC100,000$1.36M0.4%N/A0.362% 11/13/2023 FMR LLC529,544$7.19M0.0%-27.2%1.915% 11/8/2023 Swiss National Bank21,201$288K0.0%+30.9%0.077% 9/21/2023 Barclays PLC3,406$58K0.0%-27.8%0.012% 8/15/2023 HighVista Strategies LLC41,803$717K0.3%+164.0%0.151% 8/14/2023 Great Point Partners LLC932,158$15.99M3.1%+23.4%3.377% 8/14/2023 TCG Crossover Management LLC2,201,274$37.75M6.2%+103.6%7.976% 8/14/2023 Driehaus Capital Management LLC1,194,091$20.48M0.3%N/A4.326% 7/31/2023 Strs Ohio2,300$39K0.0%N/A0.008% 6/1/2023Golden State Equity Partners10,530$212K0.1%N/A0.042% 5/16/2023 Great Point Partners LLC755,620$15.24M3.0%+99.6%3.046% 5/16/2023 Atlas Venture Life Science Advisors LLC2,039,249$41.13M5.6%+1.1%8.219% 5/16/2023 Baker BROS. Advisors LP1,963,479$39.60M0.2%-0.7%7.914% 5/15/2023 Ghost Tree Capital LLC200,000$4.03M1.2%+48.1%0.806% 5/12/2023 Nan Fung Group Holdings Ltd47,936$967K0.7%-5.3%0.193% 5/11/2023 Skandinaviska Enskilda Banken AB publ50,866$1.03M0.0%-4.6%0.205% 3/23/2023 MetLife Investment Management LLC5,228$153K0.0%N/A0.021% 2/15/2023 Eversept Partners LP91,252$2.67M0.2%N/A0.374% 2/15/2023 Atlas Venture Life Science Advisors LLC2,017,521$59.11M7.1%-13.3%8.265% 2/15/2023 Nantahala Capital Management LLC15,700$460K0.0%N/A0.064% 2/14/2023 VR Adviser LLC747,869$21.91M3.5%-10.3%3.064% 2/14/2023 Parkwood LLC20,560$602K0.1%-3.7%0.084% 2/10/2023Cheyne Capital Management UK LLP18,927$555K1.0%N/A0.078% 2/8/2023 Skandinaviska Enskilda Banken AB publ53,340$1.56M0.0%-5.5%0.219% 2/8/2023 Swiss National Bank20,701$607K0.0%N/A0.085% 11/15/2022 TCG Crossover Management LLC959,572$15.91M4.8%+7.9%3.931% 11/15/2022 Citadel Advisors LLC1,615,578$26.79M0.0%+1.5%6.619% 11/14/2022 Lynx1 Capital Management LP276,447$4.58M4.1%+44.3%1.133% 11/14/2022 Cormorant Asset Management LP2,330,691$38.64M2.7%+34.7%9.548% The #1 Crypto That You Don’t Own… Yet (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details…11/14/2022 Boothbay Fund Management LLC35,757$593K0.0%N/A0.146% 11/14/2022Ergoteles LLC10,574$175K0.0%-41.3%0.043% 11/14/2022 VR Adviser LLC833,927$13.83M2.0%+41.2%3.416% 11/14/2022 Parkwood LLC21,344$354K0.1%-34.2%0.087% 11/14/2022 Altium Capital Management LP51,000$846K0.3%N/A0.209% 11/14/2022 Ghost Tree Capital LLC150,000$2.49M0.7%N/A0.615% 11/9/2022 Atlas Venture Life Science Advisors LLC2,327,909$38.60M4.3%-11.8%9.537% 11/8/2022 New York State Common Retirement Fund7,686$127K0.0%+48.2%0.031% 8/16/2022 Parkwood LLC32,414$32K0.1%N/A0.133% 8/4/2022 Chicago Partners Investment Group LLC10,163$226K0.0%N/A0.042% 8/3/2022 Atlas Venture Life Science Advisors LLC2,638,297$41.24M6.9%-15.0%10.808% 7/29/2022 Russell Investments Group Ltd.2,056$32K0.0%N/A0.008% 6/30/2022 Amalgamated Bank1,462$27K0.0%N/A0.006% 5/12/2022 Penn Mutual Asset Management LLC17,458$320K0.4%N/A0.072% 5/11/2022 Skandinaviska Enskilda Banken AB publ14,108$259K0.0%N/A0.058% 5/10/2022 Sectoral Asset Management Inc.218,913$4.01M0.7%-22.6%0.897% 5/5/2022 New York State Common Retirement Fund12,591$231K0.0%+164.0%0.052% 2/18/2022 TCG Crossover Management LLC853,330$10.06M4.7%N/A3.496% 2/14/2022 Citadel Advisors LLC1,597,479$18.84M0.0%+0.2%6.544% 2/11/2022 Parkwood LLC37,156$438K0.1%-22.7%0.152% 2/3/2022OUP Management Co. LLC603,762$7.12M3.2%N/A2.473% 2/2/2022 New York State Common Retirement Fund4,770$56K0.0%+165.0%0.020% 11/16/2021 Citadel Advisors LLC1,594,813$32.41M0.0%-1.2%6.533% 11/15/2021 Point72 Asset Management L.P.53,872$1.13M0.0%N/A0.221% 11/15/2021 Sectoral Asset Management Inc341,367$7.16M0.6%-31.7%1.398% 11/12/2021 Geode Capital Management LLC114,423$2.40M0.0%N/A0.469% 11/9/2021 BlackRock Inc.483,018$10.13M0.0%N/A1.979% 11/4/2021 Deutsche Bank AG5,794$122K0.0%N/A0.024% 11/2/2021 New York State Common Retirement Fund1,800$38K0.0%N/A0.007% 10/22/2021 Strs Ohio2,300$48K0.0%N/A0.009% 8/17/2021 Millennium Management LLC65,043$1.49M0.0%N/A0.281% 8/17/2021 Citadel Advisors LLC1,614,998$35.47M0.0%N/A6.989% 8/16/2021 Squarepoint Ops LLC9,000$205K0.0%N/A0.039% 8/16/2021 RA Capital Management L.P.8,263,982$188.67M3.0%N/A35.762% 8/16/2021 Maven Securities LTD9,854$225K0.0%N/A0.043% 8/16/2021 Goldman Sachs Group Inc.104,755$2.39M0.0%N/A0.453% (Data available from 1/1/2016 forward) AVTE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AVTE shares? During the previous two years, 40 institutional investors and hedge funds held shares of Aerovate Therapeutics. The most heavily invested institutionals were Atlas Venture Life Science Advisors LLC ($41.13M), Baker BROS. Advisors LP ($39.60M), Cormorant Asset Management LP ($38.64M), TCG Crossover Management LLC ($37.75M), Citadel Advisors LLC ($26.79M), Great Point Partners LLC ($23.48M), and VR Adviser LLC ($21.91M).Learn more on AVTE's institutional investors. Which institutional investors have been buying Aerovate Therapeutics stock? Of the 30 institutional investors that purchased Aerovate Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Driehaus Capital Management LLC ($1.19M), TCG Crossover Management LLC ($1.19M), Cormorant Asset Management LP ($600K), Great Point Partners LLC ($553.64K), Vestal Point Capital LP ($400K), Ikarian Capital LLC ($367.97K), and VR Adviser LLC ($243.52K). How much institutional buying is happening at Aerovate Therapeutics? Institutional investors have bought a total of 5,385,047 shares in the last 24 months. This purchase volume represents approximately $101.86M in transactions. Which Aerovate Therapeutics major shareholders have been selling company stock? Of the 14 institutional investors that sold Aerovate Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Atlas Venture Life Science Advisors LLC ($1.09M), FMR LLC ($198.07K), Octagon Capital Advisors LP ($93.69K), VR Adviser LLC ($86.06K), Great Point Partners LLC ($53.54K), Fred Alger Management LLC ($33.13K), and Parkwood LLC ($16.72K). How much institutional selling is happening at Aerovate Therapeutics? Institutional investors have sold a total of 1,601,659 shares in the last 24 months. This volume of shares sold represents approximately $31.55M in transactions. Related Companies: CytomX Therapeutics Institutional Ownership Gossamer Bio Institutional Ownership Immunic Institutional Ownership 89bio Institutional Ownership Leap Therapeutics Institutional Ownership Zai Lab Institutional Ownership Galapagos Institutional Ownership Keros Therapeutics Institutional Ownership Protagonist Therapeutics Institutional Ownership NewAmsterdam Pharma Institutional Ownership This page (NASDAQ:AVTE) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.